Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 202pembrolizumab 166Pemetrexed 140Cisplatin 124Paclitaxel 77durvalumab 74osimertinib 69Nivolumab 68Docetaxel 66Specimen Handling 64atezolizumab 57Magnetic Resonance Spectroscopy 53Etoposide 47Gemcitabine 46Radiotherapy 43Radiosurgery 40130-nm albumin-bound paclitaxel 34Drug Therapy 32Bevacizumab 29Ipilimumab 28Cetuximab 27cemiplimab 25Taxes 24tislelizumab 21Immunoglobulin G 21Platinum 20Biopsy 20amivantamab 19Radiation 19Disulfides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
sonidegib × Thoracic × 90 days × Clear all
NCT04007744 2026-03-18

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Active not recruiting
36 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡